Art
J-GLOBAL ID:201202248503770813   Reference number:12A1745243

Neoadjuvant treatments for triple-negative breast cancer (TNBC)

トリプルネガティブ乳癌(TNBC)のネオアジュバント療法
Author (2):
Material:
Volume: 23  Issue: Supplement 6  Page: VI35-VI39  Publication year: 2012 
JST Material Number: W0107A  ISSN: 0923-7534  CODEN: ANONE2  Document type: Article
Article type: 文献レビュー  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1745243&from=J-GLOBAL&jstjournalNo=W0107A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for tumors 
Reference (48):
  • Cleere DW. Triple-negative breast cancer: a clinical update. Community Oncol 2011; 7: 203-211.
  • Clarke M, Coates AS, Darby SC et al. Adjuvant chemotherapy in oestrogenreceptor- poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008; 371: 29-40.
  • Berry DA, Cirrincione C, Henderson IC et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006; 295: 1658-1667.
  • Budman DR, Berry DA, Cirrincione CT et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 1998; 90: 1205-1211.
  • Citron ML, Berry DA, Cirrincione C et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 2003; 21: 1431-1439.
more...
Terms in the title (2):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page